Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

<h4>Background</h4>Prostate cancer is initially dependent on androgens for survival and growth, making hormonal therapy the cornerstone treatment for late-stage tumors. However, despite initial remission, the cancer will inevitably recur. The present study was designed to investigate how...

Full description

Bibliographic Details
Main Authors: Rute B Marques, Natasja F Dits, Sigrun Erkens-Schulze, Wytske M van Weerden, Guido Jenster
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-10-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20976069/pdf/?tool=EBI